Treatment as Prevention¨

Stop jailing HIV-positive Canadians for not telling sex partners: Doctors

Canadians living with HIV/AIDS should no longer face a possible prison sentence for failing to disclosure their HIV status to sexual partners, says an acclaimed Canadian doctor who helped revolutionize the treatment of HIV worldwide. Today’s triple drug cocktails known as HAART, or highly active antiretroviral therapy, can reduce the viral load of people living […]

Stop jailing HIV-positive Canadians for not telling sex partners: Doctors Read More »

Treatment as Prevention named in Time Magazine’s “Top 10 Medical Breakthroughs of 2011”

The treatment of HIV has come a long way, thanks to antiretroviral (ARV) drugs that can lower levels of the virus in the body, keeping people healthy and reducing the risk of HIV transmission. Increasingly, though, studies have also shown that the same drugs used to treat existing infections can also help protect HIV-free people

Treatment as Prevention named in Time Magazine’s “Top 10 Medical Breakthroughs of 2011” Read More »

U.S. Secretary of State Hillary Clinton endorses the made-in-BC Strategy of Treatment as Prevention

U.S. Secretary of State Hillary Clinton announced today that “Treatment as Prevention” is integral to the global fight against HIV/AIDS. “Let’s end the old debate over treatment versus prevention and embrace treatment as prevention,” she said this morning in Washington, D.C. Clinton emphasized that effective drug treatment is key to preventing further transmission of HIV

U.S. Secretary of State Hillary Clinton endorses the made-in-BC Strategy of Treatment as Prevention Read More »

A global plea for treatment

The clock is ticking. Dr. Julio Montaner, the world-renowned HIV researcher of the B.C. Centre for Excellence in HIV/AIDS, has made an urgent plea to the medical community to recognize that treating patients with highly active antiretroviral therapy (HAART) doubles as an effective tool against the spread of the incurable virus. Montaner and his team

A global plea for treatment Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below